With a background in management, international sales and marketing, Tristan is a master at turning go-to-market strategies into gone-to-market success stories. Prior to Unorthodox Ventures, he led international offices in Asia and Australia for fan and light maker Big Ass Fans. Among his accomplishments was rapidly growing Australian revenue by $10 million, doubling the office’s sales.

At Unorthodox Ventures, he leads the investment team, responsible for seeking out the best of the best in medtech. The firm’s portfolio of nearly two dozen mid- and late-stage startups includes Laplace Interventional, CorFlow and Elucid, as well as several from the famed Shifamed medtech innovation hub.

With the resources of a VC but just a single LP, Unorthodox Ventures makes investing decisions quickly and focuses on long-term success, not short-term cashouts. The firm’s medtech investments focus on companies that have completed first-in-human testing with check sizes ranging from $1 million to $5 million. Follow-on investments are common.